Press Release

Akebia Therapeutics to Report Third Quarter 2023 Financial Results and Discuss Recent Business Highlights

October 31, 2023 at 8:00 AM EDT

Akebia to Host Conference Call on November 8th at 8:00 a.m. ET

CAMBRIDGE, Mass., Oct. 31, 2023 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2023 on Wednesday, November 8, 2023, prior to the open of financial markets.

Akebia will host a conference call on Wednesday, November 8 at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call by phone, please click on this Registration Link and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia's website at: An online archive of the webcast can be accessed via the Investors section of Akebia's website at

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco

Cision View original content to download multimedia:

SOURCE Akebia Therapeutics

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us